HSBC Holdings
HRMY icon

HSBC Holdings’s Harmony Biosciences HRMY Stock Holding History

HSBC Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$963K Sell
26,627
-39,407
-60% -$1.24M ﹤0.01% 1966
2026
Q1 		$1.86M Buy
66,034
+7,445
+13% +$244K ﹤0.01% 1560
2025
Q4 		$2.19M Buy
58,589
+21,919
+60% +$721K ﹤0.01% 1530
2025
Q3 		$1.01M Buy
36,670
+10,878
+42% +$375K ﹤0.01% 1789
2025
Q2 		$815K Buy
25,792
+3,989
+18% +$128K ﹤0.01% 1899
2025
Q1 		$714K Buy
21,803
+1,402
+7% +$50.3K ﹤0.01% 1910
2024
Q4 		$701K Buy
20,401
+2,424
+13% +$83.3K ﹤0.01% 1982
2024
Q3 		$715K Sell
17,977
-5,823
-24% -$205K ﹤0.01% 1843
2024
Q2 		$731K Buy
23,800
+16,076
+208% +$483K ﹤0.01% 1807
2024
Q1 		$259K Buy
+7,724
New +$248K ﹤0.01% 2534
2023
Q4 		– Sell
-10,026
Closed -$331K – 2806
2023
Q3 		$331K Buy
+10,026
New +$348K ﹤0.01% 2173
2023
Q1 		– Sell
-9,783
Closed -$530K – 2830
2022
Q4 		$530K Buy
9,783
+4,227
+76% +$232K ﹤0.01% 2263
2022
Q3 		$247K Buy
+5,556
New +$271K ﹤0.01% 2519
2022
Q2 		– Sell
-7,290
Closed -$363K – 3330
2022
Q1 		$363K Buy
+7,290
New +$297K ﹤0.01% 2634

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings's HRMY Position: Q2 2026 in Review

HSBC Holdings reduced its Harmony Biosciences (HRMY) stake by 60% in Q2 2026, selling an estimated $1.24M and leaving 26,627 shares worth $963K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

HSBC Holdings first reported a position in HRMY in Q1 2022 and has held it in 14 quarters since. The position peaked at $2.19M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • HSBC Holdings held 26,627 shares of Harmony Biosciences worth $963K as of Q2 2026.
  • HSBC Holdings sold 39,407 Harmony Biosciences shares in Q2 2026, an estimated $1.24M.
  • Harmony Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1966 holding.
  • HSBC Holdings first reported a position in Harmony Biosciences in Q1 2022 and has held it in 14 quarters since.
  • HSBC Holdings's Harmony Biosciences position peaked at $2.19M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.